Application of Nutraceuticals for the Management of COVID-19
★★★★★
★★★★★
English
Application of Nutraceuticals for the Management of COVID-19 provides evidence-based findings in the therapeutic role and mechanisms of phytochemicals for better prevention and treatment of patients with COVID-19. Coverage includes a scientific and evidence-based approach to a wide range of nutraceuticals that have been identified due to their anti-inflammatory and immune system-modulating properties. This is the perfect reference for pharmaceutical researchers with practical ideas for research on the effective therapeutic role of phytochemicals in COVID-19; as well as clinical experts looking to make better decisions in the use of effective supplements for the management of COVID-19.
See more
Current price
€140.39
Original price
€155.99
Save 10%
Will deliver when available. Publication date 15 Sep 2024
Product Details
Dimensions: 191 x 235mm
Publication Date: 15 Sep 2024
Publisher: Elsevier Science Publishing Co Inc
Publication City/Country: United States
Language: English
ISBN13: 9780443220050
About
Dr. Amirhossein Sahebkar received his PharmD and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad Iran). His research focuses on the investigation of novel natural products for the management of severe cardiometabolic disorders. He has conducted numerous research projects dealing with basic experimental and clinical research on curcuminoids. Thozhukat Sathyapalan (Sathya) is the academic lead for diabetes endocrinology and metabolism research in the Clinical Sciences Centre at the Hull York Medical School. He is also an Honorary Consultant Endocrinologist at Hull and East Yorkshire Hospitals NHS Trust UK. His main area of research is on modulation of cardiovascular risk through pharmacological and nutritional interventions in insulin resistant states such as obesity polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus. He is interested in traditional as well as novel risk factors specifically endocrine disruptors.